Annovis Bio, Inc. - 8-K Filing
Annovis Bio, Inc. enters into an underwriting agreement for a $21.0 million public offering of common stock and warrants. (Items: 1.01 Entry into a Material Definitive Agreement, 7.01 Regulation FD Disclosure On November 4, 2026, the Company issued a press release announcing the launch of the Offering, 9.01 Financial Statements and Exhibits Exhibit Number Description 4)
Tickers: $ANVS